Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Valeant’s Pearson Is Out, As Hunt Begins For A CEO To Right The Wrongs

This article was originally published in The Pink Sheet Daily

Executive Summary

Valeant has begun the search for a new CEO, who will be charged with turning around the troubled company and likely divesting some assets. The company also calls out former CFO Howard Schiller for “improper conduct.”

Advertisement

Related Content

2016 Pharma Dealmaking: Waiting On The High-Value Deals
Legislators And Bond Holders Knocking At Valeant’s Door
Eye On The Prize: For $8.7 Billion, Valeant Will Acquire Bausch & Lomb
Valeant Continues Buying Spree With $2.6B Acquisition Of Medicis
Tax Benefits Highlight Announced Merger Of Valeant And Biovail

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS079239

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel